nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP2C9—cardial valve—dilated cardiomyopathy	0.0548	0.294	CbGeAlD
Sildenafil—PDE5A—pulmonary artery—dilated cardiomyopathy	0.0543	0.291	CbGeAlD
Sildenafil—Xanthopsia—Furosemide—dilated cardiomyopathy	0.0307	0.04	CcSEcCtD
Sildenafil—Anxiety depression—Lisinopril—dilated cardiomyopathy	0.0256	0.0334	CcSEcCtD
Sildenafil—Hypoglycemic reaction—Lisinopril—dilated cardiomyopathy	0.023	0.03	CcSEcCtD
Sildenafil—Unspecified visual loss—Lisinopril—dilated cardiomyopathy	0.0193	0.0251	CcSEcCtD
Sildenafil—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0159	0.0207	CcSEcCtD
Sildenafil—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.0156	0.0203	CcSEcCtD
Sildenafil—Hypotensive—Furosemide—dilated cardiomyopathy	0.0154	0.02	CcSEcCtD
Sildenafil—ABCC5—cardiac ventricle—dilated cardiomyopathy	0.0103	0.0553	CbGeAlD
Sildenafil—ABCC5—myocardium—dilated cardiomyopathy	0.00971	0.052	CbGeAlD
Sildenafil—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00922	0.012	CcSEcCtD
Sildenafil—ABCC10—cardiac ventricle—dilated cardiomyopathy	0.00862	0.0462	CbGeAlD
Sildenafil—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00834	0.0109	CcSEcCtD
Sildenafil—Ear disorder—Lisinopril—dilated cardiomyopathy	0.0078	0.0102	CcSEcCtD
Sildenafil—Blindness—Lisinopril—dilated cardiomyopathy	0.0076	0.0099	CcSEcCtD
Sildenafil—PDE5A—heart—dilated cardiomyopathy	0.00741	0.0397	CbGeAlD
Sildenafil—Ataxia—Spironolactone—dilated cardiomyopathy	0.00704	0.00916	CcSEcCtD
Sildenafil—ABCC5—heart—dilated cardiomyopathy	0.00677	0.0363	CbGeAlD
Sildenafil—Fluid overload—Lisinopril—dilated cardiomyopathy	0.00677	0.00881	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00674	0.00878	CcSEcCtD
Sildenafil—Gastritis—Spironolactone—dilated cardiomyopathy	0.00662	0.00862	CcSEcCtD
Sildenafil—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00605	0.00787	CcSEcCtD
Sildenafil—Gout—Furosemide—dilated cardiomyopathy	0.00601	0.00782	CcSEcCtD
Sildenafil—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00596	0.00776	CcSEcCtD
Sildenafil—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00589	0.00767	CcSEcCtD
Sildenafil—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00584	0.0076	CcSEcCtD
Sildenafil—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00584	0.0076	CcSEcCtD
Sildenafil—ABCC5—cardiac atrium—dilated cardiomyopathy	0.00579	0.0311	CbGeAlD
Sildenafil—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00572	0.00745	CcSEcCtD
Sildenafil—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00571	0.00744	CcSEcCtD
Sildenafil—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00568	0.0074	CcSEcCtD
Sildenafil—Renal failure—Spironolactone—dilated cardiomyopathy	0.00567	0.00738	CcSEcCtD
Sildenafil—ABCC10—heart—dilated cardiomyopathy	0.00566	0.0303	CbGeAlD
Sildenafil—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00519	0.00676	CcSEcCtD
Sildenafil—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00508	0.00661	CcSEcCtD
Sildenafil—Bladder pain—Furosemide—dilated cardiomyopathy	0.00507	0.0066	CcSEcCtD
Sildenafil—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00489	0.00637	CcSEcCtD
Sildenafil—ABCC10—cardiac atrium—dilated cardiomyopathy	0.00484	0.026	CbGeAlD
Sildenafil—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00479	0.0257	CbGeAlD
Sildenafil—ABCC10—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00476	0.104	CbGpPWpGaD
Sildenafil—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00476	0.00619	CcSEcCtD
Sildenafil—ABCC4—heart—dilated cardiomyopathy	0.0047	0.0252	CbGeAlD
Sildenafil—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00468	0.0061	CcSEcCtD
Sildenafil—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00463	0.00603	CcSEcCtD
Sildenafil—Swelling—Furosemide—dilated cardiomyopathy	0.00461	0.00601	CcSEcCtD
Sildenafil—Cough increased—Lisinopril—dilated cardiomyopathy	0.0046	0.00599	CcSEcCtD
Sildenafil—Alopecia—Spironolactone—dilated cardiomyopathy	0.00457	0.00596	CcSEcCtD
Sildenafil—Deafness—Furosemide—dilated cardiomyopathy	0.00455	0.00593	CcSEcCtD
Sildenafil—Gout—Lisinopril—dilated cardiomyopathy	0.00451	0.00587	CcSEcCtD
Sildenafil—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00431	0.00562	CcSEcCtD
Sildenafil—Thirst—Furosemide—dilated cardiomyopathy	0.00428	0.00557	CcSEcCtD
Sildenafil—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00426	0.00555	CcSEcCtD
Sildenafil—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00418	0.00545	CcSEcCtD
Sildenafil—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00411	0.00535	CcSEcCtD
Sildenafil—Malaise—Spironolactone—dilated cardiomyopathy	0.00406	0.00529	CcSEcCtD
Sildenafil—Cystitis—Lisinopril—dilated cardiomyopathy	0.00406	0.00529	CcSEcCtD
Sildenafil—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00403	0.00525	CcSEcCtD
Sildenafil—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00399	0.0052	CcSEcCtD
Sildenafil—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00395	0.00515	CcSEcCtD
Sildenafil—Photophobia—Lisinopril—dilated cardiomyopathy	0.00395	0.00515	CcSEcCtD
Sildenafil—Irritability—Furosemide—dilated cardiomyopathy	0.00389	0.00506	CcSEcCtD
Sildenafil—Bladder pain—Lisinopril—dilated cardiomyopathy	0.0038	0.00495	CcSEcCtD
Sildenafil—Discomfort—Spironolactone—dilated cardiomyopathy	0.00379	0.00494	CcSEcCtD
Sildenafil—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00372	0.00484	CcSEcCtD
Sildenafil—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0037	0.00483	CcSEcCtD
Sildenafil—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00369	0.0048	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00367	0.00477	CcSEcCtD
Sildenafil—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00359	0.00468	CcSEcCtD
Sildenafil—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00354	0.00461	CcSEcCtD
Sildenafil—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00351	0.00457	CcSEcCtD
Sildenafil—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00345	0.00449	CcSEcCtD
Sildenafil—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00335	0.00437	CcSEcCtD
Sildenafil—Injury—Lisinopril—dilated cardiomyopathy	0.00332	0.00433	CcSEcCtD
Sildenafil—Somnolence—Spironolactone—dilated cardiomyopathy	0.00327	0.00426	CcSEcCtD
Sildenafil—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00325	0.00423	CcSEcCtD
Sildenafil—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00322	0.0042	CcSEcCtD
Sildenafil—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00321	0.00418	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00317	0.00414	CcSEcCtD
Sildenafil—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00317	0.00413	CcSEcCtD
Sildenafil—CYP1A1—heart—dilated cardiomyopathy	0.00315	0.0169	CbGeAlD
Sildenafil—Arthritis—Lisinopril—dilated cardiomyopathy	0.00314	0.00409	CcSEcCtD
Sildenafil—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00313	0.00408	CcSEcCtD
Sildenafil—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00312	0.00406	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00311	0.00405	CcSEcCtD
Sildenafil—Renal failure—Furosemide—dilated cardiomyopathy	0.00308	0.00402	CcSEcCtD
Sildenafil—Diplopia—Lisinopril—dilated cardiomyopathy	0.00305	0.00398	CcSEcCtD
Sildenafil—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00305	0.00398	CcSEcCtD
Sildenafil—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00305	0.00398	CcSEcCtD
Sildenafil—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00303	0.00395	CcSEcCtD
Sildenafil—CYP2C9—heart—dilated cardiomyopathy	0.00303	0.0162	CbGeAlD
Sildenafil—Sweating—Furosemide—dilated cardiomyopathy	0.00301	0.00392	CcSEcCtD
Sildenafil—Face oedema—Lisinopril—dilated cardiomyopathy	0.00295	0.00384	CcSEcCtD
Sildenafil—Urticaria—Spironolactone—dilated cardiomyopathy	0.00292	0.0038	CcSEcCtD
Sildenafil—Irritability—Lisinopril—dilated cardiomyopathy	0.00292	0.0038	CcSEcCtD
Sildenafil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00291	0.00379	CcSEcCtD
Sildenafil—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0029	0.00378	CcSEcCtD
Sildenafil—Ataxia—Lisinopril—dilated cardiomyopathy	0.00287	0.00374	CcSEcCtD
Sildenafil—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00279	0.00363	CcSEcCtD
Sildenafil—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00278	0.00362	CcSEcCtD
Sildenafil—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00276	0.0036	CcSEcCtD
Sildenafil—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00276	0.00359	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00275	0.00358	CcSEcCtD
Sildenafil—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00273	0.00356	CcSEcCtD
Sildenafil—Visual impairment—Furosemide—dilated cardiomyopathy	0.00271	0.00353	CcSEcCtD
Sildenafil—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00271	0.00353	CcSEcCtD
Sildenafil—Gastritis—Lisinopril—dilated cardiomyopathy	0.0027	0.00352	CcSEcCtD
Sildenafil—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.00269	0.0144	CbGeAlD
Sildenafil—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00266	0.00347	CcSEcCtD
Sildenafil—Asthma—Lisinopril—dilated cardiomyopathy	0.00264	0.00344	CcSEcCtD
Sildenafil—Influenza—Lisinopril—dilated cardiomyopathy	0.00264	0.00344	CcSEcCtD
Sildenafil—Eye disorder—Furosemide—dilated cardiomyopathy	0.00263	0.00343	CcSEcCtD
Sildenafil—Tinnitus—Furosemide—dilated cardiomyopathy	0.00263	0.00342	CcSEcCtD
Sildenafil—Pruritus—Spironolactone—dilated cardiomyopathy	0.0026	0.00339	CcSEcCtD
Sildenafil—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00257	0.00335	CcSEcCtD
Sildenafil—Angiopathy—Furosemide—dilated cardiomyopathy	0.00256	0.00333	CcSEcCtD
Sildenafil—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00254	0.00331	CcSEcCtD
Sildenafil—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00254	0.00331	CcSEcCtD
Sildenafil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00252	0.00328	CcSEcCtD
Sildenafil—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00252	0.00328	CcSEcCtD
Sildenafil—ABCC5—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.0025	0.0548	CbGpPWpGaD
Sildenafil—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00245	0.0032	CcSEcCtD
Sildenafil—Erythema—Furosemide—dilated cardiomyopathy	0.00245	0.00319	CcSEcCtD
Sildenafil—Malnutrition—Furosemide—dilated cardiomyopathy	0.00245	0.00319	CcSEcCtD
Sildenafil—Dizziness—Spironolactone—dilated cardiomyopathy	0.00243	0.00317	CcSEcCtD
Sildenafil—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00243	0.00317	CcSEcCtD
Sildenafil—Flatulence—Furosemide—dilated cardiomyopathy	0.00242	0.00315	CcSEcCtD
Sildenafil—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00241	0.00314	CcSEcCtD
Sildenafil—Weight increased—Lisinopril—dilated cardiomyopathy	0.0024	0.00313	CcSEcCtD
Sildenafil—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00238	0.0031	CcSEcCtD
Sildenafil—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00237	0.00308	CcSEcCtD
Sildenafil—Depression—Lisinopril—dilated cardiomyopathy	0.00235	0.00306	CcSEcCtD
Sildenafil—Vomiting—Spironolactone—dilated cardiomyopathy	0.00234	0.00305	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00233	0.00304	CcSEcCtD
Sildenafil—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00232	0.00302	CcSEcCtD
Sildenafil—Rash—Spironolactone—dilated cardiomyopathy	0.00232	0.00302	CcSEcCtD
Sildenafil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00232	0.00302	CcSEcCtD
Sildenafil—Renal failure—Lisinopril—dilated cardiomyopathy	0.00231	0.00301	CcSEcCtD
Sildenafil—Vision blurred—Furosemide—dilated cardiomyopathy	0.00231	0.00301	CcSEcCtD
Sildenafil—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00231	0.003	CcSEcCtD
Sildenafil—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00231	0.003	CcSEcCtD
Sildenafil—Headache—Spironolactone—dilated cardiomyopathy	0.0023	0.003	CcSEcCtD
Sildenafil—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00229	0.00298	CcSEcCtD
Sildenafil—Anaemia—Furosemide—dilated cardiomyopathy	0.00227	0.00295	CcSEcCtD
Sildenafil—Sweating—Lisinopril—dilated cardiomyopathy	0.00226	0.00294	CcSEcCtD
Sildenafil—Agitation—Furosemide—dilated cardiomyopathy	0.00225	0.00293	CcSEcCtD
Sildenafil—Haematuria—Lisinopril—dilated cardiomyopathy	0.00224	0.00292	CcSEcCtD
Sildenafil—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00222	0.00289	CcSEcCtD
Sildenafil—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00221	0.00288	CcSEcCtD
Sildenafil—Vertigo—Furosemide—dilated cardiomyopathy	0.0022	0.00287	CcSEcCtD
Sildenafil—Leukopenia—Furosemide—dilated cardiomyopathy	0.00219	0.00286	CcSEcCtD
Sildenafil—Nausea—Spironolactone—dilated cardiomyopathy	0.00218	0.00284	CcSEcCtD
Sildenafil—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00212	0.00276	CcSEcCtD
Sildenafil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.0021	0.00273	CcSEcCtD
Sildenafil—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00209	0.00272	CcSEcCtD
Sildenafil—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00208	0.00271	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00207	0.0027	CcSEcCtD
Sildenafil—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00207	0.0027	CcSEcCtD
Sildenafil—Dry mouth—Furosemide—dilated cardiomyopathy	0.00204	0.00266	CcSEcCtD
Sildenafil—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.002	0.0026	CcSEcCtD
Sildenafil—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00197	0.00257	CcSEcCtD
Sildenafil—Shock—Furosemide—dilated cardiomyopathy	0.00197	0.00256	CcSEcCtD
Sildenafil—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00196	0.00256	CcSEcCtD
Sildenafil—Flushing—Lisinopril—dilated cardiomyopathy	0.00196	0.00255	CcSEcCtD
Sildenafil—Skin disorder—Furosemide—dilated cardiomyopathy	0.00194	0.00253	CcSEcCtD
Sildenafil—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00193	0.00252	CcSEcCtD
Sildenafil—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00192	0.0025	CcSEcCtD
Sildenafil—Anorexia—Furosemide—dilated cardiomyopathy	0.00191	0.00248	CcSEcCtD
Sildenafil—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.0019	0.00248	CcSEcCtD
Sildenafil—Chills—Lisinopril—dilated cardiomyopathy	0.0019	0.00247	CcSEcCtD
Sildenafil—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00189	0.00246	CcSEcCtD
Sildenafil—Hypotension—Furosemide—dilated cardiomyopathy	0.00187	0.00243	CcSEcCtD
Sildenafil—Alopecia—Lisinopril—dilated cardiomyopathy	0.00187	0.00243	CcSEcCtD
Sildenafil—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00185	0.00241	CcSEcCtD
Sildenafil—Erythema—Lisinopril—dilated cardiomyopathy	0.00184	0.0024	CcSEcCtD
Sildenafil—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00184	0.0024	CcSEcCtD
Sildenafil—Flatulence—Lisinopril—dilated cardiomyopathy	0.00181	0.00236	CcSEcCtD
Sildenafil—Tension—Lisinopril—dilated cardiomyopathy	0.00181	0.00235	CcSEcCtD
Sildenafil—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0018	0.00234	CcSEcCtD
Sildenafil—Nervousness—Lisinopril—dilated cardiomyopathy	0.00179	0.00233	CcSEcCtD
Sildenafil—Back pain—Lisinopril—dilated cardiomyopathy	0.00178	0.00232	CcSEcCtD
Sildenafil—Somnolence—Furosemide—dilated cardiomyopathy	0.00178	0.00232	CcSEcCtD
Sildenafil—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00174	0.00227	CcSEcCtD
Sildenafil—ABCC4—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00173	0.038	CbGpPWpGaD
Sildenafil—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00173	0.00226	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00173	0.00225	CcSEcCtD
Sildenafil—Fatigue—Furosemide—dilated cardiomyopathy	0.00172	0.00225	CcSEcCtD
Sildenafil—Tremor—Lisinopril—dilated cardiomyopathy	0.00172	0.00224	CcSEcCtD
Sildenafil—Pain—Furosemide—dilated cardiomyopathy	0.00171	0.00223	CcSEcCtD
Sildenafil—Constipation—Furosemide—dilated cardiomyopathy	0.00171	0.00223	CcSEcCtD
Sildenafil—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00171	0.00222	CcSEcCtD
Sildenafil—Anaemia—Lisinopril—dilated cardiomyopathy	0.0017	0.00221	CcSEcCtD
Sildenafil—Malaise—Lisinopril—dilated cardiomyopathy	0.00166	0.00216	CcSEcCtD
Sildenafil—Vertigo—Lisinopril—dilated cardiomyopathy	0.00165	0.00215	CcSEcCtD
Sildenafil—Syncope—Lisinopril—dilated cardiomyopathy	0.00165	0.00215	CcSEcCtD
Sildenafil—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00165	0.00215	CcSEcCtD
Sildenafil—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00165	0.00214	CcSEcCtD
Sildenafil—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00164	0.00213	CcSEcCtD
Sildenafil—Palpitations—Lisinopril—dilated cardiomyopathy	0.00163	0.00212	CcSEcCtD
Sildenafil—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00162	0.00211	CcSEcCtD
Sildenafil—Cough—Lisinopril—dilated cardiomyopathy	0.00161	0.00209	CcSEcCtD
Sildenafil—Urticaria—Furosemide—dilated cardiomyopathy	0.00159	0.00207	CcSEcCtD
Sildenafil—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00158	0.00206	CcSEcCtD
Sildenafil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00158	0.00206	CcSEcCtD
Sildenafil—Myalgia—Lisinopril—dilated cardiomyopathy	0.00157	0.00204	CcSEcCtD
Sildenafil—Chest pain—Lisinopril—dilated cardiomyopathy	0.00157	0.00204	CcSEcCtD
Sildenafil—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00157	0.00204	CcSEcCtD
Sildenafil—Anxiety—Lisinopril—dilated cardiomyopathy	0.00156	0.00203	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00156	0.00203	CcSEcCtD
Sildenafil—Discomfort—Lisinopril—dilated cardiomyopathy	0.00155	0.00202	CcSEcCtD
Sildenafil—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00153	0.00199	CcSEcCtD
Sildenafil—Oedema—Lisinopril—dilated cardiomyopathy	0.0015	0.00196	CcSEcCtD
Sildenafil—Infection—Lisinopril—dilated cardiomyopathy	0.00149	0.00194	CcSEcCtD
Sildenafil—Shock—Lisinopril—dilated cardiomyopathy	0.00148	0.00192	CcSEcCtD
Sildenafil—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00147	0.00192	CcSEcCtD
Sildenafil—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00147	0.00191	CcSEcCtD
Sildenafil—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00146	0.0019	CcSEcCtD
Sildenafil—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00145	0.00189	CcSEcCtD
Sildenafil—Asthenia—Furosemide—dilated cardiomyopathy	0.00144	0.00187	CcSEcCtD
Sildenafil—Anorexia—Lisinopril—dilated cardiomyopathy	0.00143	0.00186	CcSEcCtD
Sildenafil—Pruritus—Furosemide—dilated cardiomyopathy	0.00142	0.00184	CcSEcCtD
Sildenafil—Hypotension—Lisinopril—dilated cardiomyopathy	0.0014	0.00183	CcSEcCtD
Sildenafil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00137	0.00178	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00137	0.00178	CcSEcCtD
Sildenafil—Insomnia—Lisinopril—dilated cardiomyopathy	0.00136	0.00177	CcSEcCtD
Sildenafil—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00135	0.00176	CcSEcCtD
Sildenafil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00134	0.00174	CcSEcCtD
Sildenafil—Somnolence—Lisinopril—dilated cardiomyopathy	0.00133	0.00174	CcSEcCtD
Sildenafil—Dizziness—Furosemide—dilated cardiomyopathy	0.00132	0.00172	CcSEcCtD
Sildenafil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00132	0.00172	CcSEcCtD
Sildenafil—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0013	0.0017	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0013	0.00169	CcSEcCtD
Sildenafil—Fatigue—Lisinopril—dilated cardiomyopathy	0.00129	0.00169	CcSEcCtD
Sildenafil—Pain—Lisinopril—dilated cardiomyopathy	0.00128	0.00167	CcSEcCtD
Sildenafil—Constipation—Lisinopril—dilated cardiomyopathy	0.00128	0.00167	CcSEcCtD
Sildenafil—Vomiting—Furosemide—dilated cardiomyopathy	0.00127	0.00166	CcSEcCtD
Sildenafil—Rash—Furosemide—dilated cardiomyopathy	0.00126	0.00164	CcSEcCtD
Sildenafil—Dermatitis—Furosemide—dilated cardiomyopathy	0.00126	0.00164	CcSEcCtD
Sildenafil—Headache—Furosemide—dilated cardiomyopathy	0.00125	0.00163	CcSEcCtD
Sildenafil—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00124	0.00161	CcSEcCtD
Sildenafil—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00123	0.0016	CcSEcCtD
Sildenafil—Urticaria—Lisinopril—dilated cardiomyopathy	0.00119	0.00155	CcSEcCtD
Sildenafil—Nausea—Furosemide—dilated cardiomyopathy	0.00119	0.00155	CcSEcCtD
Sildenafil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00119	0.00155	CcSEcCtD
Sildenafil—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00119	0.00155	CcSEcCtD
Sildenafil—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00111	0.00144	CcSEcCtD
Sildenafil—Asthenia—Lisinopril—dilated cardiomyopathy	0.00108	0.0014	CcSEcCtD
Sildenafil—Pruritus—Lisinopril—dilated cardiomyopathy	0.00106	0.00138	CcSEcCtD
Sildenafil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00103	0.00134	CcSEcCtD
Sildenafil—ADORA2A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00102	0.0224	CbGpPWpGaD
Sildenafil—ABCC4—Platelet degranulation—TTN—dilated cardiomyopathy	0.00101	0.0222	CbGpPWpGaD
Sildenafil—Dizziness—Lisinopril—dilated cardiomyopathy	0.000993	0.00129	CcSEcCtD
Sildenafil—ABCC4—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000964	0.0211	CbGpPWpGaD
Sildenafil—Vomiting—Lisinopril—dilated cardiomyopathy	0.000954	0.00124	CcSEcCtD
Sildenafil—Rash—Lisinopril—dilated cardiomyopathy	0.000947	0.00123	CcSEcCtD
Sildenafil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000946	0.00123	CcSEcCtD
Sildenafil—Headache—Lisinopril—dilated cardiomyopathy	0.00094	0.00122	CcSEcCtD
Sildenafil—Nausea—Lisinopril—dilated cardiomyopathy	0.000892	0.00116	CcSEcCtD
Sildenafil—ABCC4—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000878	0.0192	CbGpPWpGaD
Sildenafil—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000836	0.0183	CbGpPWpGaD
Sildenafil—ABCC4—Platelet degranulation—VCL—dilated cardiomyopathy	0.000746	0.0163	CbGpPWpGaD
Sildenafil—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000711	0.0156	CbGpPWpGaD
Sildenafil—ADORA2A—Monoamine Transport—AGT—dilated cardiomyopathy	0.000683	0.015	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TTN—dilated cardiomyopathy	0.000602	0.0132	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000566	0.0124	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00055	0.0121	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000546	0.012	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000535	0.0117	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000535	0.0117	CbGpPWpGaD
Sildenafil—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000535	0.0117	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.000535	0.0117	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000522	0.0114	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000508	0.0111	CbGpPWpGaD
Sildenafil—PDE6G—beta-catenin independent WNT signaling—RAC1—dilated cardiomyopathy	0.000505	0.0111	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000498	0.0109	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.000496	0.0109	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000449	0.00984	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—VCL—dilated cardiomyopathy	0.000444	0.00973	CbGpPWpGaD
Sildenafil—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000438	0.00959	CbGpPWpGaD
Sildenafil—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000403	0.00882	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000399	0.00874	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000389	0.00853	CbGpPWpGaD
Sildenafil—ADORA2A—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000384	0.00842	CbGpPWpGaD
Sildenafil—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	0.000374	0.0082	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000369	0.00808	CbGpPWpGaD
Sildenafil—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000357	0.00782	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000331	0.00725	CbGpPWpGaD
Sildenafil—ABCC4—Platelet degranulation—CD36—dilated cardiomyopathy	0.00032	0.007	CbGpPWpGaD
Sildenafil—ADORA2A—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000311	0.00683	CbGpPWpGaD
Sildenafil—ADORA2A—Monoamine Transport—TNF—dilated cardiomyopathy	0.000309	0.00678	CbGpPWpGaD
Sildenafil—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000304	0.00667	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000289	0.00633	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000281	0.00616	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000281	0.00616	CbGpPWpGaD
Sildenafil—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.000276	0.00606	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—RAC1—dilated cardiomyopathy	0.000267	0.00586	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000261	0.00573	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000247	0.00541	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.000246	0.0054	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000238	0.00521	CbGpPWpGaD
Sildenafil—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000237	0.0052	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TTN—dilated cardiomyopathy	0.000231	0.00507	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000223	0.00489	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000221	0.00484	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000214	0.00469	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000204	0.00446	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000204	0.00446	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	0.000201	0.0044	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0002	0.00439	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000195	0.00427	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000195	0.00427	CbGpPWpGaD
Sildenafil—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000194	0.00425	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—CD36—dilated cardiomyopathy	0.00019	0.00417	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ANKRD1—dilated cardiomyopathy	0.00019	0.00416	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000189	0.00415	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000183	0.00402	CbGpPWpGaD
Sildenafil—PDE6G—Disease—NPPA—dilated cardiomyopathy	0.000183	0.00401	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000183	0.004	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000181	0.00397	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—RAC1—dilated cardiomyopathy	0.000179	0.00393	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—TAZ—dilated cardiomyopathy	0.000179	0.00391	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PSEN2—dilated cardiomyopathy	0.000177	0.00388	CbGpPWpGaD
Sildenafil—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000177	0.00388	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000173	0.0038	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	0.000171	0.00374	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000168	0.00367	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—SDHA—dilated cardiomyopathy	0.000162	0.00354	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000157	0.00343	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000155	0.0034	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000155	0.0034	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000154	0.00338	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000149	0.00325	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000147	0.00322	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000144	0.00316	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000142	0.00311	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00014	0.00306	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000138	0.00302	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000134	0.00293	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000124	0.00272	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000124	0.00272	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000123	0.00269	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00012	0.00264	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00012	0.00263	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000119	0.00261	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—RAF1—dilated cardiomyopathy	0.000119	0.0026	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000113	0.00248	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000113	0.00247	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000111	0.00243	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00011	0.00241	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00011	0.00241	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00011	0.00241	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00011	0.0024	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000109	0.00238	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000108	0.00237	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000107	0.00234	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000106	0.00232	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000106	0.00232	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000103	0.00226	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000102	0.00224	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000101	0.00221	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000101	0.00221	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.91e-05	0.00217	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NPPA—dilated cardiomyopathy	9.87e-05	0.00216	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	9.57e-05	0.0021	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PSEN2—dilated cardiomyopathy	9.56e-05	0.0021	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	9e-05	0.00197	CbGpPWpGaD
Sildenafil—PDE6G—Disease—RAC1—dilated cardiomyopathy	8.9e-05	0.00195	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	8.86e-05	0.00194	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	8.76e-05	0.00192	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	8.76e-05	0.00192	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	8.56e-05	0.00188	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.47e-05	0.00186	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	8.39e-05	0.00184	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	8.29e-05	0.00182	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—RAF1—dilated cardiomyopathy	8.22e-05	0.0018	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.14e-05	0.00178	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	8.14e-05	0.00178	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.03e-05	0.00176	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.96e-05	0.00174	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.96e-05	0.00174	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.89e-05	0.00173	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	7.46e-05	0.00164	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.4e-05	0.00162	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	7.33e-05	0.00161	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	7.31e-05	0.0016	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.16e-05	0.00157	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	6.93e-05	0.00152	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	6.92e-05	0.00152	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.9e-05	0.00151	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	6.88e-05	0.00151	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.74e-05	0.00148	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	6.54e-05	0.00143	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	6.52e-05	0.00143	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	6.5e-05	0.00143	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.39e-05	0.0014	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RAC1—dilated cardiomyopathy	6.24e-05	0.00137	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	6.15e-05	0.00135	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.12e-05	0.00134	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AGT—dilated cardiomyopathy	5.96e-05	0.00131	CbGpPWpGaD
Sildenafil—PDE6G—Disease—RAF1—dilated cardiomyopathy	5.9e-05	0.00129	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	5.89e-05	0.00129	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	5.88e-05	0.00129	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.8e-05	0.00127	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.7e-05	0.00125	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—EGFR—dilated cardiomyopathy	5.63e-05	0.00123	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	5.56e-05	0.00122	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	5.35e-05	0.00117	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.29e-05	0.00116	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	5.03e-05	0.0011	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.96e-05	0.00109	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	4.92e-05	0.00108	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	4.88e-05	0.00107	CbGpPWpGaD
Sildenafil—ABCC5—Disease—RAC1—dilated cardiomyopathy	4.81e-05	0.00105	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.74e-05	0.00104	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.7e-05	0.00103	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.7e-05	0.00103	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	4.63e-05	0.00101	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	4.59e-05	0.001	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	4.56e-05	0.001	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	4.55e-05	0.000996	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.51e-05	0.000987	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GPX1—dilated cardiomyopathy	4.39e-05	0.000961	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.37e-05	0.000957	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.3e-05	0.000943	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CD36—dilated cardiomyopathy	4.27e-05	0.000936	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.23e-05	0.000927	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	4.18e-05	0.000917	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	4.15e-05	0.000909	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RAF1—dilated cardiomyopathy	4.13e-05	0.000906	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EGFR—dilated cardiomyopathy	4.05e-05	0.000887	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.95e-05	0.000866	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AGT—dilated cardiomyopathy	3.85e-05	0.000843	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.61e-05	0.000792	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.43e-05	0.000751	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.39e-05	0.000743	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.3e-05	0.000723	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.22e-05	0.000705	CbGpPWpGaD
Sildenafil—ABCC5—Disease—RAF1—dilated cardiomyopathy	3.19e-05	0.000699	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.02e-05	0.000663	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.99e-05	0.000655	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.97e-05	0.000651	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.95e-05	0.000646	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—dilated cardiomyopathy	2.84e-05	0.000621	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.77e-05	0.000608	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.73e-05	0.000599	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.7e-05	0.000592	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.66e-05	0.000583	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.54e-05	0.000557	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.53e-05	0.000554	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.46e-05	0.00054	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.43e-05	0.000533	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.22e-05	0.000486	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	2.21e-05	0.000484	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—dilated cardiomyopathy	2.19e-05	0.000479	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	2.15e-05	0.000472	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.05e-05	0.000449	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.94e-05	0.000425	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.76e-05	0.000387	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	1.6e-05	0.000351	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.6e-05	0.00035	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	1.56e-05	0.000342	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.56e-05	0.000341	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	1.51e-05	0.000331	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	1.47e-05	0.000322	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	1.4e-05	0.000308	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.4e-05	0.000307	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	1.32e-05	0.00029	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.24e-05	0.000271	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.21e-05	0.000265	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.2e-05	0.000264	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.14e-05	0.000249	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.13e-05	0.000247	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	0.000242	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.1e-05	0.00024	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.08e-05	0.000237	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	9.96e-06	0.000218	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	9.88e-06	0.000216	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	7.43e-06	0.000163	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	7.24e-06	0.000159	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	6.51e-06	0.000143	CbGpPWpGaD
